Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tandem Diabetes Care
(NQ:
TNDM
)
34.31
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tandem Diabetes Care
< Previous
1
2
3
4
5
6
Next >
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
December 10, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
November 21, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
November 06, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
October 30, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 02, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
September 19, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
August 26, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
August 19, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
August 12, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
August 01, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
July 30, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
July 29, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
July 11, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
June 22, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
June 20, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
June 18, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
May 29, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
May 23, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
May 02, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
April 29, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 23, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
April 09, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Parexel Announces CEO Succession Plan
March 18, 2024
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024
From
Parexel International LLC
Via
GlobeNewswire
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
March 06, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
March 04, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Inc. (NASDAQ: TNDM) Making Surprising Moves in Thursday Session
February 22, 2024
Via
Investor Brand Network
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
February 21, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
February 13, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
February 08, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.